This website uses cookies to give you the best user experience. If you continue
without changing your settings we'll assume you are happy to receive all RSC cookies.
You can change your cookie settings by navigating to our Privacy and Cookies page and following the instructions. These instructions
are also obtainable from the privacy link at the bottom of any RSC page.
Global R&D Operations, Analytical Development, Johnson & Johnson Group of Consumer Companies, 185 Tabor Road, Morris Plains
b
Department of Chemistry and Biochemistry, Center for Academic Industry Partnership, Seton Hall University, 400 South Orange Avenue, South Orange
E-mail: Nicholas.snow@shu.edu
; Fax: +973-761-9772
; Tel: +973-761-9035
Anal. Methods, 2010,2, 722-727
DOI:
10.1039/B9AY00284G
Received
03 Dec 2009,
Accepted
07 Mar 2010
First published online
31 Mar 2010
A simple gradient reversed-phase high performance liquid chromatography (HPLC) method was developed for the simultaneous determination of total benzalkonium chloride (BAC) and pramoxine HCl in wound care solutions. Laboratory formulations were diluted 1:10 with water and injected into a HPLC system equipped with a Phenomenex, Luna CN column (100 Å, 5μm, 250 mm × 4.6 mm) in order for BAC and pramoxine to separate from other excipients and be detected by a UV detector (λ = 262 nm). The mobile phase was 0.075 mM sodium acetate trihydratebuffer (pH = 5.0) using multi-ramp gradient elution with acetonitrile. Quantitation was achieved by direct comparison of the peaks of BAC and pramoxine HCl of the sample to a reference standard of known concentrations. A stress study with acid, base, peroxide, heat, and light indicated no interference from drug product or excipients. The mean recovery results for both pramoxine and benzalkonium chloride at 100% level were 100.5 ± 0.3%, 100.5 ± 0.1% respectively (mean ± SD, n = 6). In this report, the full experimental results from developing and validating this method are presented.
A simple gradient reversed-phase high performance liquid chromatography (HPLC) method was developed for the simultaneous determination of total benzalkonium chloride (BAC) and pramoxine HCl in wound care solutions. Laboratory formulations were diluted 1 : 10 with water and injected into a HPLC system equipped with a Phenomenex, Luna CN column (100 Å, 5µm, 250 mm × 4.6 mm) in order for BAC and pramoxine to separate from other excipients and be detected by a UV detector (λ = 262 nm). The mobile phase was 0.075 mM sodium acetate trihydrate buffer (pH = 5.0) using multi-ramp gradient elution with acetonitrile. Quantitation was achieved by direct comparison of the peaks of BAC and pramoxine HCl of the sample to a reference standard of known concentrations. A stress study with acid, base, peroxide, heat, and light indicated no interference from drug product or excipients. The mean recovery results for both pramoxine and benzalkonium chloride at 100% level were 100.5 ± 0.3%, 100.5 ± 0.1% respectively (mean ± SD, n = 6). In this report, the full experimental results from developing and validating this method are presented.
Fetching data from CrossRef. This may take some time to load.